|
rs6078460
|
|
Liver carcinoma
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Genomewide association study for C-reactive protein in Indians replicates known associations of common variants.
|
30945673 |
2019 |
|
rs584368
|
|
Liver carcinoma
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Genomewide association study for C-reactive protein in Indians replicates known associations of common variants.
|
30945673 |
2019 |
|
rs584368
|
|
Liver carcinoma
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Genome-Wide Association Study Identifies a Genetic Prediction Model for Postoperative Survival in Patients with Hepatocellular Carcinoma.
|
30945699 |
2019 |
|
rs5000634
|
|
Liver carcinoma
|
|
0.700 |
GeneticVariation
|
GWASDB |
Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma.
|
23242368 |
2013 |
|
rs405
|
|
Liver carcinoma
|
|
0.700 |
GeneticVariation
|
GWASDB |
GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers.
|
22807686 |
2012 |
|
rs3135363
|
|
Liver carcinoma
|
|
0.700 |
GeneticVariation
|
GWASDB |
Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma.
|
23242368 |
2013 |
|
rs3094137
|
|
Liver carcinoma
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma.
|
29784950 |
2018 |
|
rs2856723
|
|
Liver carcinoma
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Human leukocyte antigen variants and risk of hepatocellular carcinoma modified by hepatitis C virus genotypes: A genome-wide association study.
|
28921602 |
2018 |
|
rs2856683
|
|
Liver carcinoma
|
|
0.700 |
GeneticVariation
|
GWASDB |
Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma.
|
23242368 |
2013 |
|
rs2647012
|
|
Liver carcinoma
|
|
0.700 |
GeneticVariation
|
GWASDB |
Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma.
|
23242368 |
2013 |
|
rs17007417
|
|
Liver carcinoma
|
T |
0.700 |
GeneticVariation
|
GWASCAT |
Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers.
|
29385134 |
2018 |
|
rs10484561
|
|
Liver carcinoma
|
|
0.700 |
GeneticVariation
|
GWASDB |
Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma.
|
23242368 |
2013 |
|
rs8099917
|
|
Liver carcinoma
|
|
0.090 |
GeneticVariation
|
BEFREE |
The T/T genotype of rs8099917 was not associated with the development of HCC (p = 0.623), although stepwise logistic regression analysis showed that liver cirrhosis, age greater than 68 years, and serum albumin <4.2 mg/dl were associated with HCC onset.
|
22245236 |
2012 |
|
rs8099917
|
|
Liver carcinoma
|
|
0.090 |
GeneticVariation
|
BEFREE |
The results showed that the IL28B rs8099917 AA genotype (AA vs AC + CC: odds ratio (OR) = 0.63, 95 % confidence interval (CI) = 0.46-0.87) was associated with a decreased risk of hepatocellular carcinoma (HCC).
|
24026885 |
2014 |
|
rs8099917
|
|
Liver carcinoma
|
|
0.090 |
GeneticVariation
|
BEFREE |
Sensitivity analyses suggested the robustness of the results in this meta-analysis.Both IL28B rs12979860 CC and rs8099917 TT genotypes are protective factors for the development of HCC among patients with HBV or HCV infection.
|
31568008 |
2019 |
|
rs8099917
|
|
Liver carcinoma
|
|
0.090 |
GeneticVariation
|
BEFREE |
In participants with HCV genotype 1, unfavorable genotypes for HCV clearance near IFNL3 were associated with increased HCC risk, the adjusted odds ratio (95% CI) for rs12979860 and rs8099917 being 1.73 (1.00-2.99) and 1.84 (1.02-3.33), respectively.
|
26602024 |
2015 |
|
rs8099917
|
|
Liver carcinoma
|
|
0.090 |
GeneticVariation
|
BEFREE |
Genotyping of 183 patients with HCC with CHC who were treated with hepatic resection or radiofrequency ablation (RFA) was carried out, and the results were analyzed to determine the association between the IL-28B genotype (rs8099917) and clinical outcome.
|
23426277 |
2013 |
|
rs8099917
|
|
Liver carcinoma
|
|
0.090 |
GeneticVariation
|
BEFREE |
We genotyped the rs8099917 single-nucleotide polymorphism in 351 hepatitis C-associated HCC patients without history of IFN-based treatment, and correlated the age at onset of HCC in patients with each genotype.
|
23689989 |
2014 |
|
rs8099917
|
|
Liver carcinoma
|
|
0.090 |
GeneticVariation
|
BEFREE |
rs8099917 nonTT is related to higher HCC development in patients with HCV genotype 1 and those treated with pegylated interferon and ribavirin.
|
23860735 |
2014 |
|
rs8099917
|
|
Liver carcinoma
|
|
0.090 |
GeneticVariation
|
BEFREE |
To evaluate the role of host IL28B (interleukin 28B; interferon lambda 3) single nucleotide polymorphisms (SNPs) in predicting hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) susceptibility, three SNPs in the IL28B gene (rs12979860C/T, rs8099917G/T and rs12980275G/A) were examined in 330 subjects (including 154 HBV-related HCC patients, 86 non-HCC patients with chronic hepatitis B (CHB), 43 HBV self-limited infections and 47 healthy controls).
|
22310928 |
2012 |
|
rs8099917
|
|
Liver carcinoma
|
|
0.090 |
GeneticVariation
|
BEFREE |
the Interferon lambda (IFNL) polymorphisms genotypes (rs8099917, rs12979860 and rs12980275) and the presence of mutations in HCV core protein were analyzed in 59 patients with HCC, and also in 50 cirrhotic patients (without HCC).
|
27035616 |
2016 |
|
rs6025211
|
|
Liver carcinoma
|
|
0.020 |
GeneticVariation
|
BEFREE |
Combinations of single nucleotide polymorphisms WWOX-rs13338697, GALNT14-rs9679162 and rs6025211 effectively stratify outcomes of chemotherapy in advanced hepatocellular carcinoma.
|
28695683 |
2018 |
|
rs6025211
|
|
Liver carcinoma
|
|
0.020 |
GeneticVariation
|
BEFREE |
Here, we aimed to investigate whether combination of three previously identified single nucleotide polymorphism (SNP) predictors (GALNT14-rs9679162, WWOX-rs13338697, and rs6025211) could guide our choice between systemic chemotherapy, HAIC, and targeted agents in aHCC patients.
|
31611591 |
2020 |
|
rs12980275
|
|
Liver carcinoma
|
|
0.020 |
GeneticVariation
|
BEFREE |
To evaluate the role of host IL28B (interleukin 28B; interferon lambda 3) single nucleotide polymorphisms (SNPs) in predicting hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) susceptibility, three SNPs in the IL28B gene (rs12979860C/T, rs8099917G/T and rs12980275G/A) were examined in 330 subjects (including 154 HBV-related HCC patients, 86 non-HCC patients with chronic hepatitis B (CHB), 43 HBV self-limited infections and 47 healthy controls).
|
22310928 |
2012 |
|
rs12980275
|
|
Liver carcinoma
|
|
0.020 |
GeneticVariation
|
BEFREE |
the rs12980275-AG genotype was associated with HCC on age-adjusted analysis (OR 2.42, 95% CI 1.03-5.69, P=0.043).
|
27035616 |
2016 |